(Q81835985)
Statements
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction (English)
S Tyring
M Lahfa
J Prinz
A M Nakanishi
R Zitnik
P C M van de Kerkhof
Linda Melvin
Etanercept Psoriasis Study Group